Bd to acquire edwards lifesciences' critical care product group for $4.2 billion to expand smart connected care solutions and become an advanced monitoring technology leader

Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to bd revenue growth, adjusted gross margin, adjusted operating margin and adjusted eps expands bd's portfolio of smart connected care solutions with complementary and broad set of leading monitoring technologies, advanced ai-enabled clinical decision tools and robust innovation pipeline critical care to operate as a separate business unit within bd's medical segment, based in irvine, calif. and led by katie szyman franklin lakes, n.j.
BDX Ratings Summary
BDX Quant Ranking